Saudi Pharma JV Boosts Local Production

  Published 10 months ago

Joint venture in Saudi Arabia combines PPI's market expertise with Shilpa's R&D, manufacturing capabilities strategically.

  • Phase 1: Shilpa supplies bulk products; PPI repackages locally, enabling rapid market entry within Saudi Arabia.
  • Phase 2: Full technology transfer lets JV produce finished products locally, boosting self‑sufficiency for Saudi.
  • Shilpa handles the SFDA regulatory dossier; PPI equips the facility to meet international quality standards and compliance.

You might like these

Sonata Software Q1 Revenue Rises 17%

Iveco Shares Fall on Tata, Leonardo Deals

Prestige Estates Q1 Sales Soar

JSW Steel Q1 Profit Doubles

Natco Pharma Up 3.3% After Court Ruling

Bondada's Rs 836 Crore BESS Project Boosts Tamil Nadu Renewables

HSBC: India's Earnings Recovery Delayed, Stock Picks Highlighted

News that matters the most ⚡